UBE2Q1 and hepatocellular carcinoma: Expectedly, the prognosticators of early stage laryngopharyngeal cohort were completely unique and included TWISTNB and UBE2Q1, previously designated poor prognosticators in breast and hepatocellular cancers [69,70].